Cannara Biotech Inc.
LOVE.V
TSX
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.42M | 9.35M | 11.14M | 9.68M | 4.80M |
| Total Depreciation and Amortization | 4.80M | 4.80M | 4.46M | 4.67M | 4.61M |
| Total Amortization of Deferred Charges | 99.70K | 65.30K | 237.70K | 237.70K | 209.30K |
| Total Other Non-Cash Items | 7.34M | 4.63M | 174.50K | -2.34M | 506.50K |
| Change in Net Operating Assets | -4.80M | -4.44M | -1.34M | -4.29M | 1.67M |
| Cash from Operations | 15.87M | 14.41M | 14.67M | 7.96M | 11.80M |
| Capital Expenditure | -6.97M | -4.55M | -3.84M | -4.53M | -4.34M |
| Sale of Property, Plant, and Equipment | 113.40K | 115.60K | 21.90K | 1.55M | 1.55M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 192.00K | 178.60K | 151.40K | 141.10K | 123.70K |
| Cash from Investing | -6.67M | -4.26M | -3.67M | -2.84M | -2.67M |
| Total Debt Issued | 0.00 | 500.00K | 500.00K | 2.70M | 3.70M |
| Total Debt Repaid | -3.14M | -3.08M | -3.00M | -4.35M | -4.74M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | -4.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.41M | -3.74M | -3.79M | -3.28M | -3.81M |
| Cash from Financing | -4.68M | -4.53M | -4.50M | -3.55M | -3.57M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.52M | 5.63M | 6.50M | 1.57M | 5.57M |